aliskiren 150 MG Oral Tablet [Tekturna]
- RxCUI
- 1011738
- RxNorm name
- aliskiren 150 MG Oral Tablet [Tekturna]
- Display name
- TEKTURNA (Oral Pill)
- Full name
- aliskiren 150 MG Oral Tablet [Tekturna]
- Term type
- SBD
- Status
- Active
- Strength
- 150 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-26 03:52:50
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102010
- Active start
- 102010
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| aliskiren hemifumarate | 150 MG / 1 EACH | aliskiren | aliskiren |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| aliskiren | 325646 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Tekturna 150 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | aliskiren 150 MG Oral Tablet [Tekturna] | 1 | NAMES |
| RxNorm Synonym | Tekturna 150 MG Oral Tablet | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3dd61fa5-1620-4ebf-bbdb-ede29b92fce2 | 1 | CODES |
| RxCUI | 1011738 | 1 | CODES |
| MMSL_CODE | BD19232 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 70839-150-30 | 70839-150 | Tekturna aliskiren hemifumarate | LXO US Inc. | NDA021985 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tekturna | ALISKIREN HEMIFUMARATE | LXO US Inc. | 3dd61fa5-1620-4ebf-bbdb-ede29b92fce2 | 2024-03-07 | Boxed warning, Warnings, Adverse reactions | 70839-150-30 70839-150 70839015001 70839015099 70839015030 70839015090 1011738 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3dd61fa5-1620-4ebf-bbdb-ede29b92fce2 | Tekturna 150 MG Oral Tablet [PSN] · aliskiren 150 MG Oral Tablet [Tekturna] [SBD] · Tekturna 150 MG Oral Tablet [SY] | 3 | 16 | These highlights do not include all the information needed to use TEKTURNA safely and effectively. See full prescribing information for TEKTURNA. TEKTURNA ® (aliskiren) tablets, for oral use Initial U.S. Approval: 2007 | 20240307 |
| 4c222831-90af-4336-8bf6-5628ddf24326 | Tekturna 150 MG Oral Tablet [PSN] · aliskiren 150 MG Oral Tablet [Tekturna] [SBD] · Tekturna 150 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use TEKTURNA ® safely and effectively. See full prescribing information for TEKTURNA ® . Tekturna ® (aliskiren) tablets, for oral use Initial U.S. Approval: 200 7 | 20120113 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 3dd61fa5-1620-4ebf-bbdb-ede29b92fce2 | These highlights do not include all the information needed to use TEKTURNA safely and effectively. See full prescribing information for TEKTURNA. TEKTURNA ® (aliskiren) tablets, for oral use Initial U.S. Approval: 2007 | LXO US Inc. | Packaging Coordinators, LLC | Delpharm Milano S.r.l. | 20240307 |
| 02f2d79f-b896-44b7-a6ba-3ab28ddad0f2 | National Council for Prescription Drug Programs | 20120724 | |
| 3bea8b5c-0b1e-4e5f-b614-14a4d5414430 | National Council for Prescription Drug Programs | 20120724 | |
| 720b7811-4d0d-4f2e-b44f-3cf2f3d37434 | National Council for Prescription Drug Programs | 20120724 | |
| 9b7a8fa4-3518-47b3-85bc-3c531bd1e352 | National Council for Prescription Drug Programs | 20120724 | |
| 4c222831-90af-4336-8bf6-5628ddf24326 | These highlights do not include all the information needed to use TEKTURNA ® safely and effectively. See full prescribing information for TEKTURNA ® . Tekturna ® (aliskiren) tablets, for oral use Initial U.S. Approval: 200 7 | Physicians Total Care, Inc. | 20120113 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C09XA | Renin-inhibitors | ATC1-4 | aliskiren | |
| FDASPL | N0000175900 | Renin Inhibitor | EPC | has_epc | aliskiren |
| FDASPL | N0000175899 | Renin Inhibitors | MOA | has_moa | aliskiren |
| MEDRT | D000577 | Amides | CHEM | has_ingredient | aliskiren |
| MEDRT | D005650 | Fumarates | CHEM | has_ingredient | aliskiren |
| MEDRT | D013449 | Sulfonamides | CHEM | ci_chemclass | aliskiren |
| MEDRT | D001002 | Anuria | DISEASE | ci_with | aliskiren |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | aliskiren |
| MEDRT | D003920 | Diabetes Mellitus | DISEASE | ci_with | aliskiren |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | aliskiren |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | aliskiren |
| MEDRT | N0000000181 | Angiotensin-converting Enzyme Inhibitors | MOA | ci_moa | aliskiren |
| MEDRT | N0000000181 | Angiotensin-converting Enzyme Inhibitors | MOA | has_moa | aliskiren |
| MEDRT | N0000175899 | Renin Inhibitors | MOA | ci_moa | aliskiren |
| MEDRT | N0000175899 | Renin Inhibitors | MOA | has_moa | aliskiren |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | aliskiren |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 150 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA021985 |
| NAMES | Prescribable Synonym | Tekturna 150 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |